CUREXO Inc.

As of March 31, 2026, CUREXO Inc. carries a market capitalization of 602.81B, placing it among publicly traded companies globally. Its enterprise value stands at 581.75B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

CUREXO Inc.'s next confirmed earnings release is scheduled for November 16, 2026.

As of March 31, 2026, CUREXO Inc. has 41.26M shares outstanding.

As of March 31, 2026, CUREXO Inc. trades at a trailing price-to-earnings ratio of 281.04. The price-to-sales ratio is 8.47, and the price-to-book ratio stands at 6.13.

As of March 31, 2026, CUREXO Inc. trades at an EV/EBITDA multiple of 172.44 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 8.20 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 959.61 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 581.75B versus a market cap of 602.81B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, CUREXO Inc. maintains a current ratio of 16.73, meaning it holds 16.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.01, indicating moderate leverage, while an interest coverage ratio of 43.24 demonstrates strong ability to service its debt obligations.

Over the twelve months ended March 31, 2026, CUREXO Inc. posted a return on equity (ROE) of 2.22, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 0.61 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 2.05, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 2.27, useful for judging operating efficiency across full business cycles. The company generates approximately 702.16M in revenue per employee across its workforce of 101.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.32 indicates how many times CUREXO Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, CUREXO Inc. recorded 31.31M in income tax expense. That works out to an effective tax rate of 1.44, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 2.17B, leaving 2.14B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, CUREXO Inc.'s stock has declined approximately 35.25% over the past 52 weeks. The 50-day moving average sits at 8,323.20, while the 200-day moving average is 12,239.55.

Over the twelve months ended March 31, 2026, CUREXO Inc. generated 70.92B in revenue and converted that into 2.14B in net income, yielding earnings per share of 51.97. EBITDA reached 3.37B, while operating income came in at 606.24M.

As of March 31, 2026, CUREXO Inc. holds 22.05B in cash and equivalents against 990.83M in total debt, resulting in a net debt position of -16.90B. Total book value stands at 98.28B, with working capital of 84.05B providing operational flexibility.

CUREXO Inc. produced -4.82B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -2.20B in capital expenditures, free cash flow totaled -7.02B - equivalent to -170.72 per share.

Over the twelve months ended March 31, 2026, CUREXO Inc. posted a gross margin of 32.46, reflecting its pricing power and cost economics. The operating margin of 0.85 and net profit margin of 3.01 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -1.17: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.15, meaning CUREXO Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

CUREXO Inc.'s most recent stock split took place on January 11, 2018 with a 319:335 split ratio.

As of March 31, 2026, CUREXO Inc. has an Altman Z-Score of 60.30, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.